Quantbot Technologies LP Pds Biotechnology Corp Transaction History

Quantbot Technologies LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$5.68 - $11.99 $10,894 - $22,996	1,918 Added 28.19%	8,722 $53,000
Q4 2022 Feb 13, 2023	BUY	$3.28 - $13.2 $22,317 - $89,812	6,804 New	6,804 $89,000
Q2 2022 Aug 09, 2022	BUY	$3.05 - $6.68 $10,675 - $23,380	3,500 Added 500.0%	4,200 $15,000
Q1 2022 May 16, 2022	BUY	$4.78 - $8.43 $3,346 - $5,901	700 New	700 $4,000

4.05M

253K

70.4K

Ticker PDSB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,458,700
Market Cap $42.7M
Description
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.